<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Cancer Cure in a Capsule: Engineering Bacteria to Deliver Therapeutic miRNAs</title>
  <link rel="icon" type="image/x-icon" href="./pictures/logo_new.png" sizes="32x32">
  <link href="https://fonts.googleapis.com/css2?family=Poppins:wght@400;700&display=swap" rel="stylesheet">
  <style>
    /* Chirpy theme-inspired styling */
    :root {
      --body-bg: #0B1215;
      --sidebar-bg: #262B2F;
      --topbar-bg: #252525;
      --text-color: #c9d1d9;
      --heading-color: #ffffff;
      --link-color: #58a6ff;
      --link-hover-color: #79c0ff;
      --sidebar-active-color: #ffffff;
      --border-color: #30363d;
      --card-bg: #2d333b;
      --card-border-radius: 6px;
      --btn-border-color: #30363d;
      --btn-hover-bg: #30363d;
    }

    .light-mode {
      --body-bg: #FBFAF5;
      --sidebar-bg: #d1e8e0;
      --topbar-bg: #ffffff;
      --text-color: #003153;
      --heading-color: #212529;
      --link-color: #0064cf;
      --link-hover-color: #0056b3;
      --sidebar-active-color: #212529;
      --border-color: #e5e5e5;
      --card-bg: #ffffff;
      --btn-border-color: #e5e5e5;
      --btn-hover-bg: #e9ecef;
    }

    * {
      box-sizing: border-box;
      margin: 0;
      padding: 0;
    }

    body {
      font-family: 'Poppins', sans-serif;
      background-color: var(--body-bg);
      color: var(--text-color);
      display: flex;
      min-height: 100vh;
      transition: background-color 0.3s, color 0.3s;
    }

    .site-title {
      text-align: center;
      padding: 1.5rem 1rem;
      border-bottom: 1px solid var(--border-color);
    }

    .site-title img {
      width: 80px;
      height: 80px;
      border-radius: 50%;
      margin-bottom: 0.75rem;
    }

    .site-title h1 {
      font-size: 1.5rem;
      margin: 0;
      color: var(--heading-color);
    }

    .site-title p {
      font-size: 0.9rem;
      margin: 0.5rem 0 0;
      color: var(--text-color);
      opacity: 0.8;
    }

    .sidebar-menu {
      list-style: none;
      padding: 1.5rem 0;
      flex-grow: 1;
    }

    .sidebar-menu li {
      margin-bottom: 0.25rem;
    }

    .sidebar-menu a {
      display: flex;
      align-items: center;
      padding: 0.5rem 1.5rem;
      color: var(--text-color);
      text-decoration: none;
      transition: background-color 0.2s, color 0.2s;
    }

    .sidebar-menu a:hover, .sidebar-menu a.active {
      background-color: rgba(255, 255, 255, 0.1);
      color: var(--sidebar-active-color);
    }

    .sidebar-menu a.active {
      border-left: 3px solid var(--link-color);
      padding-left: calc(1.5rem - 3px);
    }

    .sidebar-menu svg {
      margin-right: 0.75rem;
      width: 20px;
      height: 20px;
      opacity: 0.7;
    }

    .main-content {
      margin-left: 260px;
      width: calc(100% - 260px);
      transition: all 0.3s ease;
    }

    .main-content.expanded {
      margin-left: 0;
      width: 100%;
    }

    .theme-toggle {
      position: fixed;
      top: 20px;
      right: 20px;
      background: var(--body-bg);
      color: white;
      border: none;
      padding: 10px 12px;
      border-radius: 5px;
      cursor: pointer;
      z-index: 1000;
    }

    body.light-mode .theme-toggle {
      color: #333;
    }

    .theme-toggle:hover {
      background: #555;
    }

    body.light-mode .theme-toggle:hover {
      background: #ddd;
    }

    .profile-img {
      width: 150px;
      height: 150px;
      border-radius: 50%;
      object-fit: cover;
      border: 5px solid var(--border-color);
    }

    .profile-links {
      display: flex;
      justify-content: center;
      gap: 1rem;
      margin-top: 1rem;
    }

    .profile-links a {
      display: flex;
      align-items: center;
      justify-content: center;
      width: 40px;
      height: 40px;
      border-radius: 50%;
      background-color: rgba(255, 255, 255, 0.1);
      color: var(--text-color);
      transition: background-color 0.2s, transform 0.2s;
    }

    .profile-links a:hover {
      background-color: rgba(255, 255, 255, 0.2);
      transform: scale(1.1);
    }

    .sidep {
      font-size: 12px;
    }

    .profile-modal {
      display: none;
      position: fixed;
      z-index: 2000;
      left: 0;
      top: 0;
      width: 100%;
      height: 100%;
      background-color: rgba(0, 0, 0, 0.8);
      opacity: 0;
      transition: opacity 0.3s ease;
    }

    .modal-content {
      position: relative;
      margin: auto;
      padding: 0;
      width: 80%;
      max-width: 700px;
      top: 50%;
      transform: translateY(-50%) scale(0.9);
      transition: transform 0.3s ease;
    }

    .modal-content img {
      width: 100%;
      height: auto;
      border-radius: 8px;
      box-shadow: 0 4px 20px rgba(0, 0, 0, 0.5);
    }

    .close-button {
      position: absolute;
      top: -40px;
      right: 0;
      color: white;
      font-size: 35px;
      font-weight: bold;
      cursor: pointer;
      z-index: 2001;
      transition: color 0.2s;
    }

    .close-button:hover {
      color: var(--link-color);
    }

    .profile-modal.show {
      display: block;
      opacity: 1;
    }

    .profile-modal.show .modal-content {
      transform: translateY(-50%) scale(1);
    }

    .profile-img {
      cursor: pointer;
      transition: transform 0.2s;
    }

    .profile-img:hover {
      transform: scale(1.05);
    }

    .nature-nugget {
      padding: 1rem 1.5rem;
      border-top: 1px solid var(--border-color);
      font-size: 0.9rem;
    }

    .nature-nugget h3 {
      color: var(--link-color);
      margin-bottom: 0.5rem;
      font-size: 1rem;
    }

    .nugget-content {
      margin-bottom: 0.5rem;
      line-height: 1.4;
      font-size: 0.75rem;
    }

    .sidebar-icon {
      width: 20px;
      height: 20px;
      margin-right: 0.75rem;
      opacity: 0.7;
      filter: invert(0);
      transition: filter 0.3s ease, opacity 0.3s ease;
    }

    body:not(.light-mode) .sidebar-icon {
      filter: invert(1);
    }

    .sidebar {
      position: fixed;
      width: 260px;
      height: 100vh;
      background-color: var(--sidebar-bg);
      border-right: 1px solid var(--border-color);
      border-right-width: 0px;
      border-top-right-radius: 0;
      display: flex;
      flex-direction: column;
      transition: transform 0.3s ease;
      z-index: 1000;
    }

    .sidebar::after {
      content: "";
      position: absolute;
      top: 40px;
      right: 0;
      width: 1px;
      height: calc(100% - 40px);
      background-color: var(--border-color);
    }

    .pull-tab {
      position: fixed;
      top: 0;
      left: 260px;
      width: 40px;
      height: 40px;
      background-color: var(--sidebar-bg);
      border: none;
      border-right: 1px solid var(--border-color);
      border-bottom: 1px solid var(--border-color);
      border-radius: 0 8px 8px 0;
      display: flex;
      align-items: center;
      justify-content: center;
      cursor: pointer;
      z-index: 1001;
    }

    .sidebar.collapsed {
      transform: translateX(-260px);
    }

    .main-content {
      margin-left: 260px;
      width: calc(100% - 260px);
      transition: margin-left 0.3s ease, width 0.3s ease;
    }

    .sidebar.collapsed ~ .main-content {
      margin-left: 40px;
      width: calc(100% - 40px);
    }

    @media (max-width: 768px) {
      .sidebar {
        transform: translateX(0);
      }

      .pull-tab {
        left: 260px;
      }

      .sidebar.collapsed {
        transform: translateX(-260px);
      }

      .main-content {
        margin-left: 260px;
      }

      .sidebar.collapsed ~ .main-content {
        margin-left: 40px;
      }
    }

    /* Blog-specific styles */
    .blog-container {
      max-width: 900px;
      margin: 0 auto;
      padding: 2rem;
      line-height: 1.7;
    }

    .blog-header {
      text-align: center;
      margin-bottom: 3rem;
      padding-bottom: 2rem;
      border-bottom: 1px solid var(--border-color);
    }

    .blog-title {
      font-size: 2.5rem;
      color: var(--heading-color);
      margin-bottom: 1rem;
      line-height: 1.2;
    }

    .blog-subtitle {
      font-size: 1.2rem;
      color: var(--text-color);
      opacity: 0.8;
      margin-bottom: 1rem;
    }

    .blog-meta {
      font-size: 0.9rem;
      color: var(--text-color);
      opacity: 0.6;
    }

    .blog-content {
      font-size: 1.1rem;
      line-height: 1.8;
    }

    .blog-content h2 {
      font-size: 1.8rem;
      color: var(--heading-color);
      margin: 2.5rem 0 1.5rem;
      padding-bottom: 0.5rem;
      border-bottom: 2px solid var(--link-color);
    }

    .blog-content h3 {
      font-size: 1.4rem;
      color: var(--heading-color);
      margin: 2rem 0 1rem;
    }

    .blog-content p {
      margin-bottom: 1.5rem;
    }

    .blog-content ul, .blog-content ol {
      margin: 1.5rem 0;
      padding-left: 2rem;
    }

    .blog-content li {
      margin-bottom: 0.5rem;
    }

    .blog-content blockquote {
      border-left: 4px solid var(--link-color);
      padding-left: 1.5rem;
      margin: 2rem 0;
      font-style: italic;
      background-color: rgba(88, 166, 255, 0.1);
      padding: 1rem 1rem 1rem 1.5rem;
      border-radius: 4px;
    }

    .highlight-box {
      background: linear-gradient(135deg, rgba(88, 166, 255, 0.1), rgba(88, 166, 255, 0.05));
      border-left: 4px solid var(--link-color);
      padding: 1.5rem;
      margin: 2rem 0;
      border-radius: 8px;
      backdrop-filter: blur(10px);
    }

    .highlight-box h4 {
      color: var(--link-color);
      margin-bottom: 1rem;
      font-size: 1.2rem;
    }

    .problem-box {
      background: linear-gradient(135deg, rgba(220, 53, 69, 0.1), rgba(220, 53, 69, 0.05));
      border-left: 4px solid #dc3545;
      padding: 1.5rem;
      margin: 2rem 0;
      border-radius: 8px;
    }

    .problem-box h4 {
      color: #dc3545;
      margin-bottom: 1rem;
      font-size: 1.2rem;
    }

    .success-box {
      background: linear-gradient(135deg, rgba(40, 167, 69, 0.1), rgba(40, 167, 69, 0.05));
      border-left: 4px solid #28a745;
      padding: 1.5rem;
      margin: 2rem 0;
      border-radius: 8px;
    }

    .success-box h4 {
      color: #28a745;
      margin-bottom: 1rem;
      font-size: 1.2rem;
    }

    .code-block {
      background-color: var(--card-bg);
      border: 1px solid var(--border-color);
      border-radius: 8px;
      padding: 1.5rem;
      margin: 1.5rem 0;
      overflow-x: auto;
      font-family: 'Courier New', monospace;
      font-size: 0.9rem;
    }

    .component-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
      gap: 1.5rem;
      margin: 2rem 0;
    }

    .component-card {
      background: linear-gradient(135deg, rgba(255, 255, 255, 0.1), rgba(255, 255, 255, 0.05));
      border: 1px solid var(--border-color);
      border-radius: 12px;
      padding: 1.5rem;
      transition: transform 0.2s, box-shadow 0.2s;
    }

    .component-card:hover {
      transform: translateY(-2px);
      box-shadow: 0 8px 25px rgba(0, 0, 0, 0.15);
    }

    .component-card h4 {
      color: var(--link-color);
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }

    .back-link {
      display: inline-flex;
      align-items: center;
      color: var(--link-color);
      text-decoration: none;
      font-weight: 500;
      margin-bottom: 2rem;
      transition: color 0.2s;
    }

    .back-link:hover {
      color: var(--link-hover-color);
    }

    .back-link svg {
      margin-right: 0.5rem;
      width: 16px;
      height: 16px;
    }

    .tag-list {
      display: flex;
      flex-wrap: wrap;
      gap: 0.5rem;
      margin: 2rem 0;
    }

    .tag {
      background-color: rgba(88, 166, 255, 0.2);
      color: var(--link-color);
      padding: 0.3rem 0.8rem;
      border-radius: 20px;
      font-size: 0.85rem;
      font-weight: 500;
    }

    .image-placeholder {
      background: linear-gradient(135deg, var(--card-bg), rgba(88, 166, 255, 0.1));
      border: 2px dashed var(--border-color);
      border-radius: 12px;
      padding: 3rem;
      text-align: center;
      margin: 2rem 0;
      color: var(--text-color);
      opacity: 0.7;
    }

    .stats-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
      gap: 1rem;
      margin: 2rem 0;
    }

    .stat-card {
      background: linear-gradient(135deg, rgba(88, 166, 255, 0.1), rgba(88, 166, 255, 0.05));
      border-radius: 8px;
      padding: 1.5rem;
      text-align: center;
    }

    .stat-number {
      font-size: 2rem;
      font-weight: bold;
      color: var(--link-color);
      display: block;
    }

    .stat-label {
      font-size: 0.9rem;
      color: var(--text-color);
      opacity: 0.8;
    }
  </style>
</head>
<body>
  <!-- Sidebar -->
  <aside class="sidebar">
    <div class="pull-tab" id="pull-tab"></div>
    <div class="site-title">
      <img src="./pictures/profile-picture.jpeg" alt="Tuhin Kumar Raut" class="profile-img">
      <div id="profileModal" class="profile-modal">
        <div class="modal-content">
          <span class="close-button">&times;</span>
          <img id="modalImage" src="" alt="Tuhin Kumar Raut">
        </div>
      </div>
      <h1>Hi, I'm Tuhin</h1>
      <sidep>Bio Buff | Nature Nerd | Gadget Geek</sidep>
      <div class="profile-links">
        <a href="mailto:tuhinraut@gmail.com" aria-label="Email">
          <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor" width="22" height="22">
            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M3 8l7.89 5.26a2 2 0 002.22 0L21 8M5 19h14a2 2 0 002-2V7a2 2 0 00-2-2H5a2 2 0 00-2 2v10a2 2 0 002 2z" />
          </svg>
        </a>
        <a href="https://www.linkedin.com/in/tuhin-kumar-raut-936018223/" target="_blank" aria-label="LinkedIn">
          <svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" width="20" height="20">
            <path d="M20.447 20.452h-3.554v-5.569c0-1.328-.027-3.037-1.852-3.037-1.853 0-2.136 1.445-2.136 2.939v5.667H9.351V9h3.414v1.561h.046c.477-.9 1.637-1.85 3.37-1.85 3.601 0 4.267 2.37 4.267 5.455v6.286zM5.337 7.433c-1.144 0-2.063-.926-2.063-2.065 0-1.138.92-2.063 2.063-2.063 1.14 0 2.064.925 2.064 2.063 0 1.139-.925 2.065-2.064 2.065zm1.782 13.019H3.555V9h3.564v11.452zM22.225 0H1.771C.792 0 0 .774 0 1.729v20.542C0 23.227.792 24 1.771 24h20.451C23.2 24 24 23.227 24 22.271V1.729C24 .774 23.2 0 22.222 0h.003z"/>
          </svg>
        </a>
        <a href="https://github.com/tuhinraut" target="_blank" aria-label="GitHub">
          <svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" width="20" height="20">
            <path d="M12 .297c-6.63 0-12 5.373-12 12 0 5.303 3.438 9.8 8.205 11.385.6.113.82-.258.82-.577 0-.285-.01-1.04-.015-2.04-3.338.724-4.042-1.61-4.042-1.61C4.422 18.07 3.633 17.7 3.633 17.7c-1.087-.744.084-.729.084-.729 1.205.084 1.838 1.236 1.838 1.236 1.07 1.835 2.809 1.305 3.495.998.108-.776.417-1.305.76-1.605-2.665-.3-5.466-1.332-5.466-5.93 0-1.31.465-2.38 1.235-3.22-.135-.303-.54-1.523.105-3.176 0 0 1.005-.322 3.3 1.23.96-.267 1.98-.399 3-.405 1.02.006 2.04.138 3 .405 2.28-1.552 3.285-1.23 3.285-1.23.645 1.653.24 2.873.12 3.176.765.84 1.23 1.91 1.23 3.22 0 4.61-2.805 5.625-5.475 5.92.42.36.81 1.096.81 2.22 0 1.606-.015 2.896-.015 3.286 0 .315.21.69.825.57C20.565 22.092 24 17.592 24 12.297c0-6.627-5.373-12-12-12"/>
          </svg>
        </a>
      </div>
    </div>
    <ul class="sidebar-menu">
      <li>
        <a href="index.html">
          <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor">
            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M3 12l2-2m0 0l7-7 7 7M5 10v10a1 1 0 001 1h3m10-11l2 2m-2-2v10a1 1 0 01-1 1h-3m-6 0a1 1 0 001-1v-4a1 1 0 011-1h2a1 1 0 011 1v4a1 1 0 001 1m-6 0h6" />
          </svg>
          Home
        </a>
      </li>
      <li>
        <a href="Projects.html">
          <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor">
            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2" />
          </svg>
          Projects
        </a>
      </li>
      <li>
        <a href="How Close Are We.html">
          <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor">
            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9.663 17h4.673M12 3v1m6.364 1.636l-.707.707M21 12h-1M4 12H3m3.343-5.657l-.707-.707m2.828 9.9a5 5 0 117.072 0l-.548.547A3.374 3.374 0 0014 18.469V19a2 2 0 11-4 0v-.531c0-.895-.356-1.754-.988-2.386l-.548-.547z" />
          </svg>
          How Close Are We?
        </a>
      </li>
      <li>
        <a href="Unexplored Ideas.html" class="active">
          <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor">
            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9.879 7.519c1.171-1.025 3.071-1.025 4.242 0 1.172 1.025 1.172 2.687 0 3.712-.203.179-.43.326-.67.442-.745.361-1.45.999-1.45 1.827v.75M21 12a9 9 0 11-18 0 9 9 0 0118 0zm-9 5.25h.008v.008H12v-.008z" />
          </svg>
          Unexplored Ideas
        </a>
      </li>
      <li>
        <a href="Biology-with-Analogy.html">
          <img src="./pictures/brain-icon.png" alt="Brain Icon" class="sidebar-icon">
          Biology-with-Analogy
        </a>
      </li>
      <li>
        <a href="contact.html">
          <img src="./pictures/form.svg" alt="Form Icon" class="sidebar-icon">
          Contact
        </a>
      </li>
    </ul>
  </aside>

  <!-- Main content -->
  <main class="main-content">
    <button class="theme-toggle" id="theme-toggle">
      <img id="theme-icon" src="./pictures/moon.png" style="width: 20px; height: 20px;">
    </button>

    <div class="blog-container">
      <a href="Unexplored Ideas.html" class="back-link">
        <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor">
          <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M15 19l-7-7 7-7" />
        </svg>
        Back to Unexplored Ideas
      </a>

      <div class="blog-header">
        <h1 class="blog-title">Cancer Cure in a Capsule: Engineering Bacteria to Deliver Therapeutic miRNAs</h1>
        <p class="blog-subtitle">Our iGEM journey to develop <i>E. coli Nissle</i> 1917 as a living drug delivery system for colorectal cancer treatment</p>
        <div class="blog-meta">Published on January 20, 2024 â€¢ 15 min read â€¢ iGEM 2024 Project</div>
        <div class="tag-list">
          <span class="tag">synthetic biology</span>
          <span class="tag">cancer therapy</span>
          <span class="tag">miRNA</span>
          <span class="tag">E. coli Nissle</span>
          <span class="tag">OMVs</span>
          <span class="tag">iGEM</span>
        </div>
      </div>

      <div class="blog-content">
        <p>What if the future of cancer treatment could be delivered in a simple capsule containing engineered bacteria? This was the ambitious question that drove our iGEM 2024 projectâ€”an attempt to transform <em>E. coli</em> Nissle 1917 into a sophisticated biological factory capable of producing and delivering therapeutic microRNAs directly to cancer cells.</p>

        <div class="stats-grid">
          <div class="stat-card">
            <span class="stat-number">1.9M</span>
            <span class="stat-label">New CRC cases worldwide (2020)</span>
          </div>
          <div class="stat-card">
              <span class="stat-number">57%</span>
<span class="stat-label">Cases diagnosed at advanced stage in India</span>
</div>
<div class="stat-card">
<span class="stat-number">128%</span>
<span class="stat-label">Projected increase in CRC cases by 2030</span>
</div>

</div>

<h2>The Problem: Cancer's Molecular Hijacking</h2>

<p>Colorectal cancer represents one of the most devastating diseases of our time, ranking as the third most commonly diagnosed cancer globally. But what makes this disease particularly insidious isn't just its prevalenceâ€”it's the molecular chaos it creates within our cells.</p>

<div class="problem-box">
<h4>The MicroRNA Disruption</h4>
<p>Cancer cells don't just grow uncontrollably; they systematically disrupt the cellular communication network. MicroRNAs (miRNAs)â€”tiny molecular regulators that normally keep cell growth in checkâ€”become dysregulated. Specifically, tumor suppressor miRNAs like miR-145 are dramatically downregulated, while oncogenic miRNAs are overexpressed. It's like having the cellular brakes fail while the accelerator gets stuck.</p>
</div>

<h3>Current Treatment Limitations</h3>

<p>Traditional cancer therapiesâ€”surgery, chemotherapy, radiationâ€”are essentially sledgehammers trying to perform microsurgery. They damage healthy tissue alongside cancerous cells, leading to severe side effects and often incomplete treatment outcomes.</p>

<ul>
<li><strong>Surgery</strong>: Risk of complications, infections, and incomplete removal</li>
<li><strong>Chemotherapy</strong>: Systemic toxicity, hair loss, nausea, immune suppression</li>
<li><strong>Radiation</strong>: Damage to surrounding healthy tissues</li>
<li><strong>Targeted Therapy</strong>: High cost, limited patient response, long-term side effects</li>
</ul>

<div class="image-placeholder">
ðŸ§¬ Conceptual diagram: Traditional therapy vs. targeted miRNA delivery approach
</div>

<h2>Our Approach: Living Drug Factories</h2>

<p>What if we could engineer bacteria to become living, intelligent drug delivery systems? Our solution centers on transforming <em>E. coli</em> Nissle 1917 (EcN)â€”a probiotic bacterium already naturally present in the human gutâ€”into sophisticated therapeutic agents.</p>

<div class="highlight-box">
<h4>Why E. coli Nissle 1917?</h4>
<p>EcN isn't your typical <em>E. coli</em>. It's a GRAS (Generally Regarded As Safe) strain that's been used as a probiotic for over a century. It naturally colonizes the gut, has an excellent safety profile, and can be engineered without the typical concerns about pathogenicity.</p>
</div>

<h3>The Four-Component System</h3>

<div class="component-grid">
<div class="component-card">
<h4>1. Novel Chassis Development</h4>
<p>We engineered EcN to overproduce Outer Membrane Vesicles (OMVs) by knocking out the tolA gene. These nanoscale spherical vesicles serve as natural delivery vehicles that can transport therapeutic cargo directly to target cells.</p>
</div>

<div class="component-card">
<h4>2. Therapeutic miRNA Production</h4>
<p>Our bacteria produce miR-145, a tumor suppressor microRNA that's significantly downregulated in colorectal cancer. By restoring this crucial regulatory molecule, we aim to reestablish normal cellular growth control.</p>
</div>

<div class="component-card">
<h4>3. Recombinant RNA-Binding Proteins</h4>
<p>We developed designer PPR (Pentatricopeptide Repeat) proteins that specifically bind to our therapeutic miRNAs, ensuring efficient packaging and delivery within the OMVs. Each PPR subunit can be engineered for specific nucleotide recognition.</p>
</div>

<div class="component-card">
<h4>4. Surface-Displayed Targeting</h4>
<p>OMVs are decorated with nanobodies specific to EGFR (Epidermal Growth Factor Receptor), which is overexpressed in CRC cells. This provides targeted delivery, ensuring therapeutic miRNAs reach cancer cells preferentially.</p>
</div>
</div>

<h2>The Science Behind the System</h2>

<h3>Outer Membrane Vesicles: Nature's Delivery System</h3>

<p>OMVs are essentially bacterial "care packages"â€”naturally occurring nanoparticles that bacteria use for intercellular communication. By knocking out the tolA gene, we dramatically increase OMV production, creating more vehicles for therapeutic delivery.</p>

<div class="code-block">
<strong>tolA Knockout Strategy:</strong><br>
1. CRISPR-Cas9 targeting of tolA gene<br>
2. Lambda-Red recombination for precise deletion<br>
3. Verification through SDS-PAGE and Western blot<br>
4. Quantification of increased OMV production
</div>

<h3>Designer RNA-Binding Proteins</h3>

<p>Our PPR proteins represent a breakthrough in RNA recognition technology. Each 35-residue PPR motif can be programmed to recognize specific nucleotides:</p>

<ul>
<li><strong>PPR2.0_A</strong>: Recognizes adenine (A)</li>
<li><strong>PPR2.0_C</strong>: Recognizes cytosine (C)</li>
<li><strong>PPR2.0_G</strong>: Recognizes guanine (G)</li>
<li><strong>PPR2.0_U</strong>: Recognizes uracil (U)</li>
</ul>

<div class="highlight-box">
<h4>Modular Design Advantage</h4>
<p>By linking specific PPR motifs through Golden Gate Assembly, we can create proteins that recognize any desired RNA sequence with high specificityâ€”like building words with molecular letters.</p>
</div>

<h3>Cre-Lox Regulation System</h3>

<p>To ensure safety and control, we implemented a sophisticated genetic switch system:</p>

<ol>
<li><strong>Bile Activation</strong>: When bacteria reach the gut, bile acids trigger Cre recombinase expression, initiating miRNA production</li>
<li><strong>Tetracycline Termination</strong>: At therapy completion, tetracycline administration triggers a second Cre-Lox event, permanently shutting down the system</li>
</ol>

<div class="image-placeholder">
ðŸ”„ Flowchart: Cre-Lox activation and termination pathway
</div>

<h2>Challenges and Limitations</h2>

<h3>Technical Hurdles</h3>

<ul>
<li><strong>Delivery Efficiency</strong>: Ensuring sufficient miRNA reaches target cells in therapeutic concentrations</li>
<li><strong>Specificity Concerns</strong>: Preventing off-target effects in healthy gut bacteria</li>
<li><strong>Stability Issues</strong>: Maintaining miRNA integrity during storage and transit</li>
<li><strong>Immune Response</strong>: Managing potential immunogenicity of engineered OMVs</li>
</ul>

<h3>Regulatory Complexity</h3>

<p>Perhaps the greatest challenge lies not in the science, but in the regulatory pathway. Engineered live bacteria as therapeutics represent a new frontier that doesn't fit neatly into existing FDA categories. The approval process would likely require:</p>

<ul>
<li>Extensive safety studies in multiple animal models</li>
<li>Containment and biodistribution studies</li>
<li>Long-term effects monitoring</li>
<li>Novel clinical trial designs</li>
</ul>

<h2>The Broader Vision</h2>

<h3>Beyond Colorectal Cancer</h3>

<p>While our project focused on CRC, the platform technology could potentially address multiple diseases by simply swapping the therapeutic cargo:</p>

<div class="component-grid">
<div class="component-card">
<h4>Inflammatory Bowel Disease</h4>
<p>Deliver anti-inflammatory cytokines directly to inflamed gut tissue</p>
</div>

<div class="component-card">
<h4>Metabolic Disorders</h4>
<p>Provide enzyme replacement therapy for genetic deficiencies</p>
</div>

<div class="component-card">
<h4>Infectious Diseases</h4>
<p>Deploy antimicrobial peptides against resistant pathogens</p>
</div>

<div class="component-card">
<h4>Autoimmune Conditions</h4>
<p>Deliver regulatory molecules to modulate immune responses</p>
</div>
</div>

<h2>The Road Ahead</h2>

<p>While our iGEM project timeline concluded, the potential for engineered probiotic therapeutics remains enormous. Current research directions that could build upon our work include:</p>

<ul>
<li>Improved OMV engineering for enhanced targeting</li>
<li>Advanced RNA delivery systems with better stability</li>
<li>Refined genetic circuits for precise control</li>
<li>Comprehensive safety assessment protocols</li>
</ul>

<h3>Industry Momentum</h3>

<p>The field of engineered living medicines is rapidly advancing, with companies like Synlogic, Seres Therapeutics, and others developing probiotic-based therapeutics. Our project contributes to this growing foundation of knowledge.</p>

<div class="highlight-box">
<h4>Future Prospects</h4>
<p>The convergence of synthetic biology, personalized medicine, and advanced manufacturing could make engineered probiotic therapeutics a reality within the next decade. The question isn't if, but whenâ€”and how we can ensure these powerful tools are developed safely and equitably.</p>
</div>

<h2>Reflections on Failure and Learning</h2>

<p>Perhaps the most valuable aspect of this project wasn't the technical achievements, but the lessons learned about scientific ambition, realistic goal-setting, and the iterative nature of discovery. In science, "failure" often provides more learning opportunities than success.</p>

<blockquote>
"The beauty of synthetic biology lies not just in what we can build, but in what we learn about life's fundamental principles through the process of trying to engineer them."
</blockquote>

<p>Our cancer cure in a capsule remains unrealizedâ€”for now. But the foundation we built, the methods we developed, and the insights we gained contribute to a growing body of knowledge that will ultimately make such therapies possible.</p>

<p><em>What do you think about the potential of engineered bacteria as living medicines? Are there aspects of this approach that excite or concern you? The future of medicine may well depend on our ability to thoughtfully navigate these possibilities.</em></p>

<div class="tag-list">
<span class="tag">synthetic biology</span>
<span class="tag">cancer therapy</span>
<span class="tag">miRNA</span>
<span class="tag">E. coli Nissle</span>
<span class="tag">OMVs</span>
<span class="tag">iGEM</span>
<span class="tag">bioengineering</span>
<span class="tag">probiotic therapeutics</span>
</div>
</div>
</div>
</main>

<script>
// Theme toggle functionality
const themeToggle = document.getElementById('theme-toggle');
const themeIcon = document.getElementById('theme-icon');
const body = document.body;

// Check for saved theme preference
const savedTheme = localStorage.getItem('theme');
if (savedTheme === 'light') {
body.classList.add('light-mode');
themeIcon.src = './pictures/sun.png';
}

themeToggle.addEventListener('click', () => {
body.classList.toggle('light-mode');

if (body.classList.contains('light-mode')) {
themeIcon.src = './pictures/sun.png';
localStorage.setItem('theme', 'light');
} else {
themeIcon.src = './pictures/moon.png';
localStorage.setItem('theme', 'dark');
}
});

// Sidebar toggle functionality
const pullTab = document.getElementById('pull-tab');
const sidebar = document.querySelector('.sidebar');

pullTab.addEventListener('click', () => {
sidebar.classList.toggle('collapsed');
});

// Profile modal functionality
const profileImg = document.querySelector('.profile-img');
const profileModal = document.getElementById('profileModal');
const modalImage = document.getElementById('modalImage');
const closeButton = document.querySelector('.close-button');

profileImg.addEventListener('click', () => {
modalImage.src = profileImg.src;
profileModal.classList.add('show');
});

closeButton.addEventListener('click', () => {
profileModal.classList.remove('show');
});

profileModal.addEventListener('click', (e) => {
if (e.target === profileModal) {
profileModal.classList.remove('show');
}
});

// Smooth scrolling for anchor links
document.querySelectorAll('a[href^="#"]').forEach(anchor => {
anchor.addEventListener('click', function (e) {
e.preventDefault();
const target = document.querySelector(this.getAttribute('href'));
if (target) {
target.scrollIntoView({
behavior: 'smooth',
block: 'start'
});
}
});
});
</script>
</body>
</html>
